Tokyo - Delayed Quote JPY
RaQualia Pharma Inc. (4579.T)
431.00
-5.00
(-1.15%)
At close: 3:30:00 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,107,575
3,107,575
1,901,202
2,918,038
2,776,233
Cost of Revenue
625,759
625,759
245,053
231,586
320,674
Gross Profit
2,481,816
2,481,816
1,656,149
2,686,452
2,455,559
Operating Expense
2,695,198
2,695,198
1,993,514
1,820,216
1,747,698
Operating Income
-213,382
-213,382
-337,365
866,236
707,861
Net Non Operating Interest Income Expense
-35,745
-35,745
-988
-8,236
21,275
Pretax Income
-357,732
-357,732
-294,049
851,011
880,579
Tax Provision
137,298
137,298
29,612
127,620
124,790
Net Income Common Stockholders
-495,031
-495,031
-323,662
723,390
755,788
Diluted NI Available to Com Stockholders
-495,031
-495,031
-323,662
723,390
755,788
Basic EPS
-22.87
-22.87
-14.98
34.50
36.07
Diluted EPS
-22.87
-22.87
-14.98
34.47
36.04
Basic Average Shares
21,645.43
21,645.43
21,606.28
20,969.38
20,953.02
Diluted Average Shares
21,838.35
21,645.43
21,606.28
20,986.08
20,970.81
Total Operating Income as Reported
-213,383
-213,383
-337,366
866,235
707,860
Total Expenses
3,320,957
3,320,957
2,238,567
2,051,802
2,068,372
Net Income from Continuing & Discontinued Operation
-495,031
-495,031
-323,662
723,390
755,788
Normalized Income
-479,876.82
-479,876.82
-306,524.85
766,294.60
750,123.48
Interest Income
8,273
8,273
9,698
13,656
22,849
Interest Expense
42,615
42,615
6,681
5,995
1,454
Net Interest Income
-35,745
-35,745
-988
-8,236
21,275
EBIT
-315,117
-315,117
-287,368
857,006
882,033
EBITDA
86,536
86,536
-111,804
1,004,737
1,023,588
Reconciled Cost of Revenue
625,759
625,759
245,053
231,586
320,674
Reconciled Depreciation
401,653
401,653
175,564
147,731
141,555
Net Income from Continuing Operation Net Minority Interest
-495,031
-495,031
-323,662
723,390
755,788
Total Unusual Items Excluding Goodwill
-19,732
-19,732
-22,314
-50,476
6,602
Total Unusual Items
-19,732
-19,732
-22,314
-50,476
6,602
Normalized EBITDA
106,268
106,268
-89,490
1,055,213
1,016,986
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4,577.82
-4,577.82
-5,176.85
-7,571.40
937.48
12/31/2021 - 7/20/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade